Physician profile
David Alevi
NPI 1669730974
$2,978.88
in general payments reported to CMS, 2019-2025
19 companies · $504 in 2025
The $504 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $988 · 2021: $384 · 2022: $262 · 2023: $152 · 2024: $688 · 2025: $504.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,345.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,344.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tarsus Pharmaceuticals, INC. | $389.59 | 2024-2025 | Xdemvy |
| Allergan, INC. | $373.00 | 2019 | |
| Aerie Pharmaceuticals, INC. | $368.98 | 2019-2021 | |
| Abbott Laboratories | $282.69 | 2022-2023 | Freestyle Libre 3 |
| Harrow Eye, LLC | $160.12 | 2025 | |
| Oculus, INC. | $155.77 | 2019 | |
| Alcon Vision LLC | $151.35 | 2025 | Rocklatan, Rhopressa |
| Alexion Pharmaceuticals, INC. | $135.00 | 2024 | Ultomiris |
| Sun Pharmaceutical Industries INC. | $125.00 | 2021 | |
| Horizon Therapeutics Plc | $124.99 | 2019 | |
| Mallinckrodt Hospital Products INC. | $119.58 | 2024 | Acthar |
| Ge Healthcare | $104.18 | 2022 | |
| Eyevance Pharmaceuticals LLC | $94.97 | 2021 | |
| Sight Sciences, INC. | $89.60 | 2019 | |
| Biotissue Holdings INC. | $85.14 | 2021-2024 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $73.58 | 2025 | Xiidra, Miebo |
| Astellas Pharma US INC | $71.95 | 2023-2024 | Izervay |
| Dompe US, INC. | $48.08 | 2024 | Oxervate |
| Amgen INC. | $25.31 | 2025 | Tepezza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Alevi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.